Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-080957·Marker Therapeutics, Inc.
Schedule 13D ownership disclosure
MARKER THERAPEUTICS ORD
Common Stock, Par Value $0.001 · CUSIP: 57055L107
Event date: 2025-08-19
- Filing-level shares
- 641,801.00
- Percent of class
- 4.96%
- John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017Reported CIK 0001755569
Shares: 641,801.00 · Class: 4.96%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-080957
- Form type
- SCHEDULE 13D/A
- Filer
- Marker Therapeutics, Inc.
- CIK
- CIK 1094038
- Filed
- Aug 20, 2025
- Reporting period
- Aug 19, 2025
- Description
- Schedule 13D beneficial ownership